GB0718814D0 - Bioactive peptide - Google Patents

Bioactive peptide

Info

Publication number
GB0718814D0
GB0718814D0 GBGB0718814.7A GB0718814A GB0718814D0 GB 0718814 D0 GB0718814 D0 GB 0718814D0 GB 0718814 A GB0718814 A GB 0718814A GB 0718814 D0 GB0718814 D0 GB 0718814D0
Authority
GB
United Kingdom
Prior art keywords
bioactive peptide
bioactive
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0718814.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UK Secretary of State for Defence
Original Assignee
UK Secretary of State for Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UK Secretary of State for Defence filed Critical UK Secretary of State for Defence
Priority to GBGB0718814.7A priority Critical patent/GB0718814D0/en
Publication of GB0718814D0 publication Critical patent/GB0718814D0/en
Priority to PCT/GB2008/003272 priority patent/WO2009040543A2/en
Priority to GB0817673A priority patent/GB2453251A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
GBGB0718814.7A 2007-09-26 2007-09-26 Bioactive peptide Ceased GB0718814D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0718814.7A GB0718814D0 (en) 2007-09-26 2007-09-26 Bioactive peptide
PCT/GB2008/003272 WO2009040543A2 (en) 2007-09-26 2008-09-26 Bioactive peptide
GB0817673A GB2453251A (en) 2007-09-26 2008-09-26 Viricidal formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0718814.7A GB0718814D0 (en) 2007-09-26 2007-09-26 Bioactive peptide

Publications (1)

Publication Number Publication Date
GB0718814D0 true GB0718814D0 (en) 2007-11-07

Family

ID=38701711

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0718814.7A Ceased GB0718814D0 (en) 2007-09-26 2007-09-26 Bioactive peptide
GB0817673A Withdrawn GB2453251A (en) 2007-09-26 2008-09-26 Viricidal formulations

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0817673A Withdrawn GB2453251A (en) 2007-09-26 2008-09-26 Viricidal formulations

Country Status (2)

Country Link
GB (2) GB0718814D0 (en)
WO (1) WO2009040543A2 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643876A (en) * 1987-03-04 1997-07-01 The United States Of America As Represented By The Department Of Health And Human Services Biologically active synthetic magainin peptides
JPH07196408A (en) * 1993-12-28 1995-08-01 Amano Pharmaceut Co Ltd Antimicrobial composition
KR19990082383A (en) * 1996-02-16 1999-11-25 스티븐슨 린다 에스. Antimicrobial peptides and their use
US6482799B1 (en) * 1999-05-25 2002-11-19 The Regents Of The University Of California Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial
US20030138403A1 (en) * 2001-06-29 2003-07-24 Maxygen Aps Interferon formulations
US6872705B2 (en) * 2001-07-13 2005-03-29 Allergan, Inc. Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions

Also Published As

Publication number Publication date
WO2009040543A2 (en) 2009-04-02
GB2453251A (en) 2009-04-01
GB0817673D0 (en) 2008-11-05
WO2009040543A3 (en) 2009-05-22

Similar Documents

Publication Publication Date Title
IL199835A0 (en) Novel antimicrobial peptides
EP2017283A4 (en) Peptide
HK1131789A1 (en) Improved antimicrobial peptides
IL203221A (en) Bioactive peptides and antibodies
ZA201000283B (en) Reinigung pegylierter polypeptide
IL202120A0 (en) Signaling peptides
HK1139421A1 (en) Antibacterial peptides
EP2010561A4 (en) Antimicrobial peptides
GB0723712D0 (en) Peptides
EP2207193A4 (en) Switch
GB0920981D0 (en) Peptides
EP2214190A4 (en) Switch
EP2123666A4 (en) Peptide
GB0618748D0 (en) Peptide
GB0703945D0 (en) Peptide
EP2188305A4 (en) Modified peptides having toxin-enhancing effects
GB0605774D0 (en) Peptide
EP2136831A4 (en) Anti-angiogenic peptides
IL197675A0 (en) Peptides
GB0708529D0 (en) Peptide standards
GB0920987D0 (en) Peptides
EP2097439A4 (en) Novel peptides
GB0718814D0 (en) Bioactive peptide
GB0817978D0 (en) Peptides
GB0812586D0 (en) Chimaeric peptide

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)